The SmartPill, a wireless ingestible capsule monitoring GI tract motility, is being discontinued by Medtronic due to challenges in the supply chain. The decision was made as alternative suppliers for critical components could not be sourced, leading to the discontinuation of global sales. The device, initially developed by the SmartPill Corporation, has been used in GI clinics for years but will no longer be available once the existing inventory is exhausted. The discontinuation has raised concerns among healthcare professionals due to the lack of similar FDA-approved devices on the market.
To Another Language
from source content
www.medscape.com
Key Insights Distilled From
by Jennie Smith at www.medscape.com 06-22-2023
http://www.medscape.com/viewarticle/993553Deeper Inquiries